Novavax, Inc.

NVAX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$187-$545-$658-$1,744
Dep. & Amort.$48$41$29$13
Deferred Tax$0$0$0$0
Stock-Based Comp.$48$85$130$184
Change in WC$48-$377-$361$1,734
Other Non-Cash-$45$81$444$137
Operating Cash Flow-$87-$714-$416$323
Investing Activities
PP&E Inv.-$15-$59-$93-$57
Net Acquisitions$193$0$0$57
Inv. Purchases-$826$0$0-$2
Inv. Sales/Matur.$444$0$0$160
Other Inv. Act.$0$0$0-$57
Investing Cash Flow-$204-$59-$93$100
Financing Activities
Debt Repay.-$4-$352$82-$128
Stock Issued$263$360$249$565
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1-$3-$6$25
Financing Cash Flow$261$4$325$462
Forex Effect-$8$3$5-$5
Net Chg. in Cash-$39-$765-$179$880
Supplemental Information
Beg. Cash$584$1,349$1,528$649
End Cash$545$584$1,349$1,528
Free Cash Flow-$100-$773-$509$265
Novavax, Inc. (NVAX) Financial Statements & Key Stats | AlphaPilot